By Professor David Lawson Morris

Journal articles

Kusamura S; Moran BJ; Sugarbaker PH; Levine EA; Elias D; Baratti D; Morris DL; Sardi A; Glehen O; Deraco M; Gilly FN; Barrios P; Quenet F; Loggie BW; Gómez Portilla A; De Hingh IHJT; Ceelen WP; Pelz JOW; Piso P; González-Moreno S; Van Der Speeten K; Chua TC; Yan TD; Liauw W, 2014, 'Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei', British Journal of Surgery, 101, pp. 1758 - 1765, http://dx.doi.org/10.1002/bjs.9674

Bahrami-B F; Ataie-Kachoie P; Pourgholami MH; Morris DL, 2014, 'P70 Ribosomal protein S6 kinase (Rps6kb1): An update', Journal of Clinical Pathology, 67, pp. 1019 - 1025, http://dx.doi.org/10.1136/jclinpath-2014-202560

Saxena A; Meteling B; Kapoor J; Golani S; Danta M; Morris DL; Bester L, 2014, 'Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: A single centre experience of 45 consecutive patients', International Journal of Surgery, 12, pp. 1403 - 1408, http://dx.doi.org/10.1016/j.ijsu.2014.07.269

Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL, 2014, 'Gene of the month: Interleukin 6 (IL-6)', Journal of Clinical Pathology, 67, pp. 932 - 937, http://dx.doi.org/10.1136/jclinpath-2014-202493

Bahrami-B F; Ataie-Kachoie P; Pourgholami MH; Morris DL, 2014, 'p70 ribosomal protein S6 kinase (Rps6kb1): An update', Journal of Clinical Pathology, http://dx.doi.org/10.1136/jclinpath-2014-202560

Amini A; Masoumi-Moghaddam S; Morris DL, 2014, 'Bromelain and N-acetylcysteine induce cytotoxic effects and reduce the expression of mucin in mucin-producing carcinoma cell lines of gastrointestinal origin', EUROPEAN JOURNAL OF CANCER, 50, pp. S43 - S43, http://dx.doi.org/10.1016/S0959-8049(14)50161-X

Masoumi-Moghaddam S; Amini A; Morris DL, 2014, 'The expression of the human Sprouty protein-1 (hSpry1) inversely correlates with proliferation, migration and invasion of the SKOV-3 and 1A9 human ovarian cancer cells', EUROPEAN JOURNAL OF CANCER, 50, pp. S42 - S42, http://dx.doi.org/10.1016/S0959-8049(14)50160-8

Masoumi-Moghaddam S; Amini A; Ehteda A; Wei AQ; Morris DL, 2014, 'The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells', Journal of Ovarian Research, 7, http://dx.doi.org/10.1186/1757-2215-7-61

Amini A; Masoumi-Moghaddam S; Ehteda A; Morris DL, 2014, 'Secreted mucins in pseudomyxoma peritonei: Pathophysiological significance and potential therapeutic prospects', Orphanet Journal of Rare Diseases, 9, http://dx.doi.org/10.1186/1750-1172-9-71

Pillai K; Ehteda A; Akhter J; Chua TC; Morris DL, 2014, 'ANTICANCER EFFECT OF BROMELAIN ALONE AND IN COMBINATION WITH CISPLATIN OR FLUOROURACIL ON MALIGNANT PERITONEAL MESOTHELIOMA CELLS', EUROPEAN JOURNAL OF CANCER, 50, pp. E66 - E66, http://dx.doi.org/10.1016/j.ejca.2014.03.247

Masoumi-Moghaddam S; Amini A; Morris DL, 2014, 'The developing story of Sprouty and cancer', Cancer and Metastasis Reviews, http://dx.doi.org/10.1007/s10555-014-9497-1

Saxena A; Bester L; Shan L; Perera M; Gibbs P; Meteling B; Morris DL, 2014, 'A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases', Journal of Cancer Research and Clinical Oncology, 140, pp. 537 - 547, http://dx.doi.org/10.1007/s00432-013-1564-4

Kirby RE; Zhao J; Chua T; Liauw W; Morris DL, 2014, 'Avoidance of early post-operative Intraperitoneal chemotherapy (EPIC) following peritonectomy with heated Intraperitoneal chemotherapy (HIPEC) significantly reduces cost and hospital stay', Open Surgical Oncology Journal, 5, pp. 1 - 5, http://dx.doi.org/10.2174/1876504101405010001

Shashank A; Shehata M; Morris DL; Thompson JF, 2014, 'Radiofrequency ablation in metastatic melanoma', Journal of Surgical Oncology, 109, pp. 366 - 369, http://dx.doi.org/10.1002/jso.23548

Pillai K; Akhter J; Chua TC; Morris DL, 2014, 'A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei', International Journal of Cancer, 134, pp. 478 - 486, http://dx.doi.org/10.1002/ijc.28380

Pillai K; Ehteda A; Akhter J; Chua TC; Morris DL, 2014, 'Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells', Anti-Cancer Drugs, 25, pp. 150 - 160, http://dx.doi.org/10.1097/CAD.0000000000000039

Chua TC; Morris DL, 2014, 'A commentary on concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: A comprehensive genetic profiling and survival analysis', Journal of Human Genetics, 59, pp. 176 - 177, http://dx.doi.org/10.1038/jhg.2014.11

Paramanathan A; Saxena A; Morris DL, 2014, 'A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours', Surgical Oncology, 23, pp. 31 - 39, http://dx.doi.org/10.1016/j.suronc.2013.12.001

Bahrami F; Morris DL; Rufener L; Pourgholami MH, 2014, 'Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer', AMERICAN JOURNAL OF CANCER RESEARCH, 4, pp. 545 - 557, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341267300012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Amini A; Masoumi-Moghaddam S; Ehteda A; Morris DL, 2014, 'Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: Significance of combination therapy', Journal of Experimental and Clinical Cancer Research, 33, http://dx.doi.org/10.1186/s13046-014-0092-7

Akhter J; Pillai K; Chua TC; Alzarin N; Morris DL, 2014, 'Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters', AMERICAN JOURNAL OF CANCER RESEARCH, 4, pp. 495 - 507, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341267300007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Al-Alem I; Pillai K; Akhter J; Chua TC; Morris DL, 2014, 'Heat sink phenomenon of bipolar and monopolar radiofrequency ablation observed using polypropylene tubes for vessel simulation', Surgical Innovation, 21, pp. 269 - 276, http://dx.doi.org/10.1177/1553350613505713

Mekkawy AH; Pourgholami MH; Morris DL, 2014, 'Human Sprouty1 suppresses growth, migration, and invasion in human breast cancer cells', Tumor Biology, 35, pp. 5037 - 5048, http://dx.doi.org/10.1007/s13277-014-1665-y

Saxena A; Chua TC; Chu FC; Ng KM; Herle P; Morris DL, 2014, 'Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases', Journal of Gastrointestinal Oncology, 5, pp. 46 - 56, http://dx.doi.org/10.3978/j.issn.2078-6891.2013.055

Mekkawy AH; Pourgholami MH; Morris DL, 2014, 'Involvement of Urokinase-Type Plasminogen Activator System in Cancer: An Overview', Medicinal Research Reviews, 34, pp. 918 - 956, http://dx.doi.org/10.1002/med.21308

Yang LS; Shan LL; Saxena A; Morris DL, 2014, 'Liver transplantation: A systematic review of long-termquality of life', Liver International, 34, pp. 1298 - 1313, http://dx.doi.org/10.1111/liv.12553

Bahrami F; Pourgholami MH; Mekkawy AH; Rufener L; Morris DL, 2014, 'Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway', AMERICAN JOURNAL OF CANCER RESEARCH, 4, pp. 558 - 571, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341267300013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shan LL; Saxena A; Shan BL; Morris DL, 2014, 'Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis', Surgical Oncology, 23, pp. 199 - 210, http://dx.doi.org/10.1016/j.suronc.2014.10.002

Williams BHM; Alzahrani NA; Chan DL; Chua TC; Morris DL, 2014, 'Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: Yes or no?', European Journal of Surgical Oncology, 40, pp. 943 - 949, http://dx.doi.org/10.1016/j.ejso.2013.10.022

Chan DL; Alzahrani NA; Morris DL; Chua TC, 2014, 'Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 31 - 41, http://dx.doi.org/10.1111/jgh.12399

Masoumi-Moghaddam S; Amini A; Morris DL, 2014, 'The developing story of Sprouty and cancer', Cancer and Metastasis Reviews, 33, pp. 695 - 720, http://dx.doi.org/10.1007/s10555-014-9497-1

Ung L; Chua TC; Morris DL, 2014, 'The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: An analysis of 257 consecutive patients from an Australian centre', Journal of Cancer Research and Clinical Oncology, 140, pp. 1037 - 1045, http://dx.doi.org/10.1007/s00432-014-1633-3

Ung L; Lam AKY; Morris DL; Chua TC, 2014, 'Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: A review', Clinical and Translational Oncology, 16, pp. 425 - 435, http://dx.doi.org/10.1007/s12094-013-1154-6

Bester L; Meteling B; Boshell D; Chua TC; Morris DL, 2014, 'Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: A review of the literature', Journal of Medical Imaging and Radiation Oncology, 58, pp. 341 - 352, http://dx.doi.org/10.1111/1754-9485.12163

Saxena A; Kapoor J; Meteling B; Morris DL; Bester L, 2014, 'Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: A large single-center experience of 40 patients', Annals of Surgical Oncology, 21, pp. 1296 - 1303, http://dx.doi.org/10.1245/s10434-013-3436-1

Amini A; Masoumi-Moghaddam S; Morris DL, 2014, '188: Bromelain and N-acetylcysteine induce cytotoxic effects and reduce the expression of mucin in mucin-producing carcinoma cell lines of gastrointestinal origin', European Journal of Cancer, 50, pp. S43 - S43, http://dx.doi.org/10.1016/s0959-8049(14)50161-x

Amini A; Masoumi-Moghaddam S; Ehteda A; Morris D, 2014, 'Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro : significance of combination therapy', Journal of Experimental & Clinical Cancer Research, 33, pp. 92 - 92, http://dx.doi.org/10.1186/preaccept-1557435139144520

Bester L; Meteling B; Boshell D; Saxena A; Morris DL, 2014, 'Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancer.', Hepat Oncol, 1, pp. 215 - 228, http://dx.doi.org/10.2217/hep.13.21

Schwarz L; Votanopoulos K; Morris D; Yonemura Y; Deraco M; Piso P; Moran B; Levine EA; Tuech J-J, 2014, 'La réalisation d’une pancréatectomie gauche au cours d’une chirurgie de cytoréduction avec CHIP est-elle raisonnable ? Résultats d’une étude multicentrique internationale', Journal de Chirurgie Viscérale, 151, pp. A27 - A27, http://dx.doi.org/10.1016/s1878-786x(14)70165-2

Ung L; Chua TC; Morris DL, 2013, 'Cure for peritoneal metastases? An evidence-based review', ANZ Journal of Surgery, 83, pp. 821 - 826, http://dx.doi.org/10.1111/ans.12306

Ataie-Kachoie P; Pourgholami MH; Morris DL, 2013, 'Minocycline regulates Hypoxia-Inducible Factor-1 alpha expression through the induction of its degradation in ovarian cancer: in vitro and in vivo studies.', MOLECULAR CANCER THERAPEUTICS, 12, http://dx.doi.org/10.1158/1535-7163.TARG-13-A7

Ung L; C. Chua T; L. Morris D, 2013, 'Peritoneal metastases of lower gastrointestinal tract origin: A comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy', Journal of Cancer Research and Clinical Oncology, 139, pp. 1899 - 1908, http://dx.doi.org/10.1007/s00432-013-1517-y

Kirby R; Liauw W; Zhao J; Morris D, 2013, 'Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures', International Journal of Surgical Oncology, 2013, http://dx.doi.org/10.1155/2013/461041

Chua TC; Quinn LE; Zhao J; Morris DL, 2013, 'Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases', Journal of Surgical Oncology, 108, pp. 81 - 88, http://dx.doi.org/10.1002/jso.23356

Yang TX; Billah B; Morris DL; Chua TC, 2013, 'Palliative resection of the primary tumour in patients with Stage IV colorectal cancer: Systematic review and meta-analysis of the early outcome after laparoscopic and open colectomy', Colorectal Disease, 15, http://dx.doi.org/10.1111/codi.12256

Morris DL, 2013, 'Peritonectomy HIPEC - Contemporary results, indications', Chinese Journal of Cancer Research, 25, pp. 373 - 374, http://dx.doi.org/10.3978/j.issn.1000-9604.2013.07.03

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'MUC1 has prognostic significance in malignant peritoneal mesothelioma', International Journal of Biological Markers, 28, pp. 303 - 312, http://dx.doi.org/10.5301/JBM.5000038

Chan DL; Morris DL; Chua TC, 2013, 'Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-A systematic review', Surgical Oncology, 22, http://dx.doi.org/10.1016/j.suronc.2013.02.009

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2013, 'Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma', Journal of Cancer Research and Clinical Oncology, 139, pp. 987 - 994, http://dx.doi.org/10.1007/s00432-013-1408-2

Pillai K; Akhter J; Chua TC; Morris DL, 2013, 'Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma', Cancer Investigation, 31, pp. 241 - 250, http://dx.doi.org/10.3109/07357907.2013.784777

Back to profile page